GOLGA6L9: A Potential Drug Target Or Biomarker (G440295)

Target Name: GOLGA6L9

NCBI ID: G440295

GOLGA6L9

GOLGA6L9: A Potential Drug Target Or Biomarker

GOLGA6L9 (GOLGA6L20) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the GOLGA family of proteins, which are involved in the regulation of cellular processes such as cell division, migration, and signaling. GOLGA6L9 has been identified as a potential drug target or biomarker due to its unique structure and its involvement in several cellular processes.

The GOLGA6L9 protein is composed of 216 amino acid residues and has a calculated molecular mass of 24.1 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. GOLGA6L9 is involved in several cellular processes, including cell division, migration, and signaling.

One of the unique features of GOLGA6L9 is its structure. GOLGA6L9 has a unique fusiform structure, which is characterized by a long, slender molecule with a narrow neck and a long, linear tail. This structure allows GOLGA6L9 to interact with other proteins and molecules in a variety of ways, including through its role in cell signaling.

In addition to its unique structure, GOLGA6L9 is also involved in several cellular processes that are critical for human health. For example, GOLGA6L9 is involved in the regulation of cell division and has been shown to play a role in the development and progression of cancer. In addition, GOLGA6L9 is involved in the regulation of cell migration and has been shown to play a role in the development of neurodegenerative diseases.

GOLGA6L9 has also been identified as a potential drug target or biomarker due to its involvement in several diseases. For example, GOLGA6L9 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, GOLGA6L9 has also been shown to be involved in the development of cancer, including breast cancer.

In conclusion, GOLGA6L9 is a protein that is expressed in various tissues of the body and is involved in several cellular processes. Its unique structure and its involvement in several cellular processes make it a potential drug target or biomarker. Further research is needed to fully understand the role of GOLGA6L9 in human health and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Golgin A6 Family Like 9

The "GOLGA6L9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6L9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets